Navigation Links
Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Date:8/19/2007

(422) (6,783)

General and

administrative (2,607) (582) (3,189)

Depreciation and

amortization (312) (312)

Interest income 1,060 1,060

Interest expense (86) (86)

Change in fair value

of warrant liability - (86) (86)

Preferred stock accretion - (310) (310)

Summary:

Income (loss) before

income taxes: (8,306) (86) (310) (1,004) (9,706)

Net income (loss): (8,307) (86) (310) (1,004) (9,707)

Net income (loss) per

share - basic

and diluted: (1.17) (0.01) (0.04) (0.14) (1.37)

Weighted average

number of shares

outstanding: 7,083,748 7,083,748

Amicus Therapeutics, Inc

Statement of Operations Information for 3 months ending June 30, 2006

Change in

Fair

Value of Preferred Stock

Warrant Stock Deemed Compen- GAAP as

Non-GAAP Liability Accretion Dividend sation Reported

Income Statement

Classifications:

Research and

development (6,295) (396) (6,691)

General and

administrative (2,202) (361) (2,563)

Depreciation and

amortization (217) (217)

Interest income 448 448

Interest expense (73)
'/>"/>

SOURCE Amicus Therapeutics

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera for Gaucher Disease
2. Amicus Therapeutics Presents Preclinical Data from Studies of Plicera for Gaucher Disease
3. Amicus Therapeutics Presents Data From Preclinical and Phase 1 Studies of Amigal for Fabry Disease
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
8. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
9. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
10. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
11. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...   , July 2, 2015 BGI ... Hong Kong has been accredited ... Kong facility is the first clinical next-generation-sequencing laboratory to ... , meeting the highest standard in clinical laboratory practices. Complementary ... 11 compliant laboratory process, and multiple ISO certifications, the ...
(Date:7/2/2015)... Agreement reinforces ...   ViiV Healthcare and Desano Pharmaceuticals (Desano) ... China of dolutegravir. The agreement will ... (API), and will allow ViiV Healthcare to offer a competitive ... name Tivicay®) for China and a ...
(Date:7/1/2015)... -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a ... targeted antiviral therapies, announced today that it will present ... in New York, NY on ... James Sapirstein , Chief Executive Officer, ... his live presentation and will be available to participate ...
Breaking Medicine Technology:BGI Receives Accreditation from the College of American Pathologists (CAP) 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... Recent Highlights Strategic plan ... Term loan repaid Revolving line of credit renewed ... announced Cogdell Spencer Inc. (the "Company" or ... partner, is a REIT focused on planning, owning, developing, constructing, ...
... March 3, 2011 Dynatronics Corporation (Nasdaq: ... FirstChoice Cooperative, a group purchasing organization (GPO) headquartered in ... 20,000 members nationwide.  The three-year agreement with FirstChoice is ... the third GPO contract signed in the past two ...
Cached Medicine Technology:Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 2Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 3Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 4Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 5Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 6Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 7Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 8Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 9Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 10Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 11Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 12Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 13Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 14Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 15Cogdell Spencer Announces Fourth Quarter 2010 Results and Completion of Strategic Plan 16Dynatronics Signs Third GPO Contract in Two Months 2
(Date:7/3/2015)... ... July 03, 2015 , ... The ... June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy Esq. ... bicyclists and practical points of investigating these types of cases. , Each year, ...
(Date:7/3/2015)... ... 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director of ... of independent freestanding emergency rooms in the United States. , “We are excited to ... said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
(Date:7/3/2015)... Abilene, Texas (PRWEB) , ... July 03, 2015 , ... ... published a new article this week that he says will reveal biblical truth and ... article titled “Why Does Your Bible Say Don’t Have Sex”, immediately goes into the ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest ... Mississippi. The premium frozen yogurt chain was listed as #22 on the Inc. 500 ... Avenue, New Albany, MS 38652, will have a grand opening event on July 4, ...
(Date:7/2/2015)... ... 2015 , ... Following the recent report by JAMA Internal Medicine ... overweight Americans, Samir Becic emphatically declared a war on obesity in the United States. ... said. "We must understand the magnitude of this discovery. For that reason, I am ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetfrog Opens First Location in Mississippi 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 2Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 3Health News:Samir Becic's Health Fitness Revolution Declares War Against Obesity in America 4
... 3 (HealthDay News) -- People with mental illness are ... serious cardiac event, a new study finds. One ... mental illness are 14 percent less likely to receive ... Those treatments included coronary artery bypass graft (bypass surgery) ...
... , THURSDAY, June 2 (HealthDay News) -- A class ... doesn,t boost the risk of cancer, as a recent ... drugs are known as angiotensin-receptor blockers (ARBs) and include ... and candesartan (Atacand). The determination comes from ...
... -- Poor sleep may be a factor in aggressive behavior ... who bully other kids are more likely to be sleepy ... the University of Michigan Medical School found that children with ... have sleep-disordered breathing problems or daytime sleepiness as other children ...
... investigates the challenges that pen and paper workarounds ... of electronic health records. Understanding these challenges may ... health IT. Focusing on referrals by primary ... specialists back to the referring physician, "Paper Persistence, ...
... American Society of Clinical Oncology (ASCO) Annual Meeting, cancer ... treating recurrent gliobastoma (GBM) has a favorable safety profile ... than the current median survival rate. Patients in ... University of California, San Francisco and Columbia University, were ...
... When earthquake, tsunami, tornado or flood strike, among the ... International Journal of Emergency Management , researchers in ... into account the age-related needs of adults with regards ... Robyn Tuohy and Christine Stephens of Massey University ...
Cached Medicine News:Health News:Mental Illness Linked to Greater Risk of Death After Heart Attack 2Health News:Popular Blood Pressure Meds Not Linked to Cancer, FDA Says 2Health News:Kids Who Bully Often Get Poor Sleep 2Health News:Paper and computer workarounds challenge but may improve health IT 2Health News:Paper and computer workarounds challenge but may improve health IT 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 4Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 5Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 6Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 7Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 8Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 9Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 10Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 11Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 12Health News:Helping the aged during natural disasters 2
Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
This ELISA test is used for the detection and semi-quantitation of lgG antibobies to proteinase 3(pr3) in human sera, as an aid to the diagnosis of wegener s granulomatosis....
... for the semi-quantitative determination of specific ... serum. The results of the anti-GBM.assay ... in the diagnosis of diseases associated ... including Goodpastures Syndrome. Levels of these ...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of LH in human serum or plasma. LH in the sample is bound by 2 monoclonal anti-LH antibodies directed at different epito...
Medicine Products: